Neuroimaging of Vessel Amyloid in Alzheimer's Disease a , b
dc.contributor.author | Friedland, Robert P. | en_US |
dc.contributor.author | Kalaria, Rajesh | en_US |
dc.contributor.author | Berridge, Marc | en_US |
dc.contributor.author | Miraldi, Floro | en_US |
dc.contributor.author | Hedera, Peter | en_US |
dc.contributor.author | Reno, John | en_US |
dc.contributor.author | Lyle, Leon | en_US |
dc.contributor.author | Marotta, Charles A. | en_US |
dc.date.accessioned | 2010-06-01T20:33:57Z | |
dc.date.available | 2010-06-01T20:33:57Z | |
dc.date.issued | 1997-09 | en_US |
dc.identifier.citation | FRIEDLAND, ROBERT P.; KALARIA, RAJESH; BERRIDGE, MARC; MIRALDI, FLORO; HEDERA, PETER; RENO, JOHN; LYLE, LEON; MAROTTA, CHARLES A. (1997). "Neuroimaging of Vessel Amyloid in Alzheimer's Disease a , b ." Annals of the New York Academy of Sciences 826(1 Cerebrovascular Pathology in Alzheimer's Disease ): 242-247. <http://hdl.handle.net/2027.42/73674> | en_US |
dc.identifier.issn | 0077-8923 | en_US |
dc.identifier.issn | 1749-6632 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/73674 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=9329695&dopt=citation | en_US |
dc.description.abstract | Despite extensive recent advances in understanding Alzheimer's disease (AD) we are unable to noninvasively establish a definite diagnosis during life and cannot monitor the cerebral deposition of amyloid Β protein (A/Β) in living patients. We evaluated the use of 10H3, a monoclonal antibody Fab targeting AΒ protein 1-28 labeled with Tc-99m. Six subjects with probable AD were studied using single-photon emission computed tomography (SPECT) at times from 0–24 hours following injection. Curves of radioactivity in blood demonstrate a half-life of the injected Fab of 2–3 hours. Images show uptake around the head in the scalp or bone marrow in all subjects. There is no evidence of cerebral uptake of the antibody. Scalp biopsies in all six patients demonstrate diffuse staining with 10H3 of the scalp, a pattern indistinguishable from that found in controls. Evidence of amyloid deposition in the scalp in AD is not seen with other anti-AΒ antibodies, suggesting that 10H3 is cross-reacting with another protein. Further studies with anti-AΒ antibodies will require longer-lived radionuclides to detect cerebral uptake at later tunes after injection to allow for complete clearance from the blood. Afternately, imaging using labeled AΒ itself may provide a means for noninvasive targeting of cerebral amyloid. | en_US |
dc.format.extent | 390645 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | 1997 The New York Academy of Sciences | en_US |
dc.title | Neuroimaging of Vessel Amyloid in Alzheimer's Disease a , b | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Science (General) | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationother | Department of Neurology, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA | en_US |
dc.contributor.affiliationother | Department of Radiology, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA | en_US |
dc.contributor.affiliationother | NeoRx Corporation, Seattle, Washington, USA | en_US |
dc.contributor.affiliationother | Mallinckrodt Medical, St. Louis, Missouri, USA | en_US |
dc.contributor.affiliationother | Miriam Hospital, Brown University, Providence, Rhode Island, USA | en_US |
dc.identifier.pmid | 9329695 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/73674/1/j.1749-6632.1997.tb48475.x.pdf | |
dc.identifier.doi | 10.1111/j.1749-6632.1997.tb48475.x | en_US |
dc.identifier.source | Annals of the New York Academy of Sciences | en_US |
dc.identifier.citedreference | Dela Torre, J. C. 1994. Impaired brain microcirculation may trigger Alzheimer's disease. Neurosc. Biobehav. Rev. 18 ( 3 ): 397 – 401. | en_US |
dc.identifier.citedreference | Scholz, W. 1938. Studien zur pathologie der hirngefassse. II. Die drusige entartung der hirnarterien und capillaren. Z. Neurol. Psychiat. 162: 694 – 715. | en_US |
dc.identifier.citedreference | Ellis, R. J. et al. 1996. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: The CERAD experience, part XV. Neurology 46: 1592 – 1596. | en_US |
dc.identifier.citedreference | Friedland, R. P. et al. 1991. Anti-amyloid antibodies for in-vivo diagnosis of Alzheimer's disease. Neurology 41 ( Suppl. 1 ): 156. | en_US |
dc.identifier.citedreference | Friedland, R. P. et al. 1991. Anti-amyloid antibodies for in-vivo immunocytochemical studies of Alzheimer's disease using neuroimaging. J. Cereb. Blood Flow Metabo. 11 ( Suppl. 2 ): S186. | en_US |
dc.identifier.citedreference | Friedland, R. P. et al. 1993. Development of a monoclonal antibody targeting the amyloid Β protein for immunochemical neuroimaging. Neurology 43: A213. | en_US |
dc.identifier.citedreference | Friedland, R. P. et al. 1993. Immunochemistry of Alzheimer's disease: Development of a monoclonal antibody targeting the amyloid Β protein for neuroimaging. J. Cereb. Blood Flow Metab. 13: S244. | en_US |
dc.identifier.citedreference | Friedland, R. P. et al. 1994. Imaging studies of a TC-99 anti AΒ Fab monoclonal antibody (MAB) in Alzheimer's disease (AD) using SPECT. Soc. Neurosci. Abstr. 20: 1057. | en_US |
dc.identifier.citedreference | Friedland, R. P. et al. 1994. Noninvasive imaging using a murine monoclonal anti-AΒ antibody Fab labeled with technetium 99m in Alzheimer's disease. Neurobiol. Aging 15 ( Suppl. 1 ): S96 – S97. | en_US |
dc.identifier.citedreference | Marotta, C. A. et al. 1995. Imaging studies with murine anti AΒ monoclonal antibody (MAB) Fab 10H3 in Alzheimer's disease (AD) patients. Neurology 45 ( Suppl 4 ): A405. ( Presented at the American Academy of Neurology, Seattle, WA, May 1995.). | en_US |
dc.identifier.citedreference | Majocha, R. E. et al. 1992. Development of a monoclonal antibody specific for Β/A4 amyloid in Alzheimer's disease brain for application to in vivo imaging of amyloid angiopathy. J. Nucl. Med. 33: 2184 – 2189. | en_US |
dc.identifier.citedreference | Friedland, R. P. et al. 1994. Development of an anti-AΒ monoclonal antibody for in vivo imaging of amyloid angiopathy in Alzheimer's disease. Mol. Neurobiol. 9: 107 – 113. | en_US |
dc.identifier.citedreference | Yamaguchi, H. et al. 1992. Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. Am J. Pathol. 141: 249 – 259. | en_US |
dc.identifier.citedreference | Zain, S. B. et al. 1988. Molecular cloning of amyloid cDNA derived from mRNA of the Alzheimer disease brain: Coding and noncoding regions of the fetal precursor mRNA are expressed in the cortex. Proc. Natl. Acad. Sci. USA 85 ( 3 ): 929 – 933. | en_US |
dc.identifier.citedreference | Majocha, R. E. 1988. Laminar-specific distribution and infrastructural detail of amyloid in the Alzheimer's disease cortex visualized by computer-enhanced imaging of epitopes recognized by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 85 ( 16 ): 6182 – 6186. | en_US |
dc.identifier.citedreference | Fritzberg, A. R. et al. 1986. Synthesis and biological evaluation of technetium-99m MG3 as a hippuran replacement. J. Nucl. Med. 27 ( 1 ): 111 – 116. | en_US |
dc.identifier.citedreference | Kramer, E. L. et al. 1993. Radioimmunolocalization of metastatic breast carcinoma using indium-111-methyl benzyl DTPA BrE-3 monoclonal antibody: Phase I study. J. Nucl. Med. 34: 1067 – 1074. | en_US |
dc.identifier.citedreference | Philpott, G. W. et al. 1995. RadioimmunoPET: Detection of colorectal carcinoma with positron-emitting copper-64-labeled monoclonal antibody. J. Nucl. Med. 36: 1818 – 1824. | en_US |
dc.identifier.citedreference | Eary, J. F. et al. 1989. Successful imaging of malignant melanoma with technetium-99m- labeled monoclonal antibodies. J. Nucl. Med. 30 ( 1 ): 25 – 32. | en_US |
dc.identifier.citedreference | Friedland, R. P. et al. 1983. Quantitative evaluation of blood brain barrier integrity in Alzheimer-type dementia: Positron emission tomographic studies with rubidium-82. Eur. Neurol. 22 ( Suppl. 2 ): 19 – 20. | en_US |
dc.identifier.citedreference | Schlageter, N. L., R. E. Carson & S. I. Rapoport. 1987. Examination of blood-brain barrier permeability in dementia of the Alzheimer type with [68Ga] EDTA and positron emission tomography. J. Cereb. Blood Flow Metab. 7 ( 1 ): 1 – 8. | en_US |
dc.identifier.citedreference | May, C. 1990. Cerebrospinal fluid production is reduced in healthy aging. Neurology 40: 500 – 503. | en_US |
dc.identifier.citedreference | Ikeda, M. et al. 1993. Diagnostic significance of skin immunolabelling with antibody against native cerebral amyloid in Alzheimer's disease. Neurosci. Lett. 150: 159 – 161. | en_US |
dc.identifier.citedreference | Maggio, J. E. et al. 1992. Reversible in vitro growth of Alzheimer disease Β-amyloid plaques by deposition of labeled amyloid peptide. Proc. Natl. Acad. Sci. USA 89: 5462 – 5466. | en_US |
dc.identifier.citedreference | Mantyh, P. W. et al. 1991. Reversible in vitro growth of Alzheimer disease beta-amyloid plaques. Bull. Clin. Neurosci. 56: 73 – 85. | en_US |
dc.identifier.citedreference | Saito, Y. et al. 1995. Vector mediated delivery of I-125-labeled beta-amyloid peptide A-beta (1–40) through the blood-brain barrier and binding to Alzheimer disease amyloid of the A-beta (1-40)/vector complex. Proc. Natl. Acad. Sci. USA 92: 10227 – 10231. | en_US |
dc.identifier.citedreference | Zlokovic, B. V. et al. 1993. Blood-brain barrier transport of circulating Alzheimer's amyloid Β. Biochem. Biophys. Res. Commun. 197: 1034 – 1040. | en_US |
dc.identifier.citedreference | Zlokovic, B. V. et al 1994. Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta. Biochem. Biophys. Res. Commun. 205: 1431 – 1437. | en_US |
dc.identifier.citedreference | Ghilardi, J. R. Intra-arterial infusion of 125I-AΒ1-40 labels amyloid deposits in the aged primate brain in vivo, NeuroReport. In press. | en_US |
dc.identifier.citedreference | Walker, L. C. et al. 1994. Labeling of cerebral amyloid in vivo with a monoclonal antibody. J. Neuropath. Exp. Neurol. 53 ( 4 ): 377 – 383. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.